The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.
Open Access
- 1 October 1990
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 30 (4) , 593-598
- https://doi.org/10.1111/j.1365-2125.1990.tb03818.x
Abstract
1. Based on the ratio of drug to active metabolite excreted in urine approximately 3% of a healthy Caucasian population showed a reduced ability to convert proguanil to cycloguanil. 2. Pharmacokinetic analysis showed that this observation resulted from a reduced oral clearance of proguanil in these individuals (245, 534 and 552 ml min‐1) compared with the rest of the population (858 +/− 482 ml min‐1). 3. Peak plasma concentrations of active metabolite were significantly lower in these subjects (54.2, 26.8 and 51.7 ng ml‐1) compared with the rest of the population (141 +/− 45.2 ng ml‐1). 4. The observed variability may result from the polymorphic metabolism of proguanil in man.This publication has 13 references indexed in Scilit:
- In vitro metabolism of the biguanide antimalarials in human liver microsomes: evidence for a role of the mephenytoin hydroxylase (P450 MP) enzyme.British Journal of Clinical Pharmacology, 1990
- Inter‐subject variability in the metabolism of proguanil to the active metabolite cycloguanil in man.British Journal of Clinical Pharmacology, 1989
- Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects.British Journal of Clinical Pharmacology, 1987
- A preliminary pharmacokinetic study of the antimalarial drugs, proguanil and chlorproguanilJournal of Pharmacy and Pharmacology, 1987
- Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in manEuropean Journal of Clinical Pharmacology, 1984
- PHENFORMIN-INDUCED LACTICACIDOSIS ASSOCIATED WITH IMPAIRED DEBRISOQUINE HYDROXYLATIONThe Lancet, 1981
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977
- The Absorption and Excretion of Paludrine in the Human SubjectPathogens and Global Health, 1946